High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma
Article
Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt, Otto, Wolfgang, Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018) High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clinical Genitourinary Cancer 16 (4), 248-256.e2.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Clinical Genitourinary Cancer | ||||
| Publisher | CIG MEDIA GROUP, LP | ||||
| Place of Publication | DALLAS | ||||
| Volume | 16 | ||||
| Number of Issue or Book Chapter | 4 | ||||
| Page Range | 248-256.e2 | ||||
| Date | 2018 | ||||
| Date of publication | 28 Jul 2021 17:09 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | MESSENGER-RNA EXPRESSION; CELL-CARCINOMA; PROGNOSTIC VALUE; ALLELIC LOSSES; CANCER; RECURRENCE; VALIDATION; GUIDELINES; MUTATIONS; SURVIVAL; CDKN2A; mRNA; NMIBC; p16; Prognosis | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 46960 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric